Evidence map›Paper›PMID 22891308›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

Triclosan impairs excitation-contraction coupling and Ca2+ dynamics in striated muscle.

Gennady Cherednichenko, Rui Zhang, Roger A Bannister, Valeriy Timofeyev, Ning Li, Erika B Fritsch, Wei Feng, Genaro C Barrientos, Nils H Schebb, Bruce D Hammock and 3 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 162 citations in OpenAlex.

  1. Review
  2. Treatment ofAntimicrobial agents and chemotherapy · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. S2k-Guideline hand antisepsis and hand hygiene.GMS hygiene and infection control · 2024
    Article
  8. Review
  9. Review
  10. Role of environmental pollutants in Alzheimer's disease: a review.Environmental science and pollution research international · 2020
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Triclosan: An Update on Biochemical and Molecular Mechanisms.Oxidative medicine and cellular longevity · 2019
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Gennady CherednichenkoDepartment of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.
Rui Zhang
Roger A Bannister
Valeriy Timofeyev
Ning Li
Erika B Fritsch
Wei Feng
Genaro C Barrientos
Nils H Schebb
Bruce D Hammock
Kurt G Beam
Nipavan Chiamvimonvat
Isaac N Pessah
University of California, Davis · USUniversity of Colorado Anschutz Medical Campus · USVA Northern California Health Care System · US

Funding

Workshop on Environmental Technology Transfer and EntrepreneurshipP42ES004699 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI HAMMOCK, BRUCE D · 1987 to 2021
$50.1M
Uncovering the Molecular Basis of Malignant HyperthermiaP01AR052354 · NIAMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HOPKINS, PHILIP · 2006 to 2016
$13.4M
UC Davis Center for Children's Environmental Health (CCEH)P01ES011269 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI VAN DE WATER, JUDY A. · 2001 to 2018
$12.5M
ENVIRONMENTAL TOXICOLOGYT32ES007059 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura S Van Winkle · 1985 to 2026
$7.9M
Functional Interactions of Cardiac Ion ChannelsR01HL085844 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CHIAMVIMONVAT, NIPAVAN · 2007 to 2025
$7.3M
Training Program In Basic & Translational Cardiovascular ScienceT32HL086350 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Martin Cadeiras, David A. Liem · 2008 to 2026
$7.1M
Translational Study of Cardiac DysfunctionR01HL085727 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CHIAMVIMONVAT, NIPAVAN, SIRISH, PADMINI · 2008 to 2022
$5.7M
HYDROLYTIC ENZYMES IN THE METABOLISM OF TOXINSR01ES002710 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI HAMMOCK, BRUCE D · 1985 to 2018
$4.0M
Regulation of Membrane ExcitabilityR01AR055104 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI BEAM, KURT G · 2008 to 2012
$3.1M
RGK proteins and aging muscleR03AG038778 · NIA · UNIVERSITY OF COLORADO DENVER · PI BANNISTER, ROGER ALAN · 2011 to 2012
$122k
Regulation of ion channels in the heartI01BX000576 · VA · VA NORTHERN CALIFORNIA HEALTH CARE SYS · PI CHIAMVIMONVAT, NIPAVAN · 2009 to 2019
–
BLRD VA I01 BX000576NHLBI NIH HHS R01 HL085727NHLBI NIH HHS R01 HL085844NHLBI NIH HHS R01 HL85727NHLBI NIH HHS R01 HL85844NHLBI NIH HHS T32 HL086350NHLBI NIH HHS T32 HL86350NIAMS NIH HHS 1P01 AR52354NIAMS NIH HHS P01 AR052354NIAMS NIH HHS R01 AR055104NIA NIH HHS R03 AG038778NIEHS NIH HHS 2P01 ES011269NIEHS NIH HHS P01 ES011269NIEHS NIH HHS P42 ES004699NIEHS NIH HHS R01 ES002710NIEHS NIH HHS T32 ES007059
6 · The paper itself

Abstract

Triclosan (TCS), a high-production-volume chemical used as a bactericide in personal care products, is a priority pollutant of growing concern to human and environmental health. TCS is capable of altering the activity of type 1 ryanodine receptor (RyR1), but its potential to influence physiological excitation-contraction coupling (ECC) and muscle function has not been investigated. Here, we report that TCS impairs ECC of both cardiac and skeletal muscle in vitro and in vivo. TCS acutely depresses hemodynamics and grip strength in mice at doses ≥12.5 mg/kg i.p., and a concentration ≥0.52 μM in water compromises swimming performance in larval fathead minnow. In isolated ventricular cardiomyocytes, skeletal myotubes, and adult flexor digitorum brevis fibers TCS depresses electrically evoked ECC within ∼10-20 min. In myotubes, nanomolar to low micromolar TCS initially potentiates electrically evoked Ca(2+) transients followed by complete failure of ECC, independent of Ca(2+) store depletion or block of RyR1 channels. TCS also completely blocks excitation-coupled Ca(2+) entry. Voltage clamp experiments showed that TCS partially inhibits L-type Ca(2+) currents of cardiac and skeletal muscle, and [(3)H]PN200 binding to skeletal membranes is noncompetitively inhibited by TCS in the same concentration range that enhances [(3)H]ryanodine binding. TCS potently impairs orthograde and retrograde signaling between L-type Ca(2+) and RyR channels in skeletal muscle, and L-type Ca(2+) entry in cardiac muscle, revealing a mechanism by which TCS weakens cardiac and skeletal muscle contractility in a manner that may negatively impact muscle health, especially in susceptible populations.

Indexed as

Age FactorsAnimalsAnimals, NewbornAnti-Infective Agents, LocalCalciumCalcium Channels, L-TypeCyprinidaeHeart FailureHumansMiceMice, Inbred C57BLMice, Mutant StrainsMotor ActivityMuscle ContractionMuscle Fibers, SkeletalMyocardial ContractionAnti-Infective Agents, LocalCalciumCalcium Channels, L-TypeRyanodine Receptor Calcium Release ChannelTriclosanWater Pollutants

Identifiers

PMID22891308
PMCPMC3435154
OpenAlexW2161237133

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.